IGF-I and IGF-II in relation to colorectal cancer
Orestis Manousos(National and Kapodistrian University of Athens), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Cristina Bosetti(Mario Negri Institute for Pharmacological Research), John Souglakos(University of Crete), Hans-Olov Adami(Karolinska Institutet), Dimitrios Trichopoulos(Dana-Farber/Harvard Cancer Center), Αναστασία Τζώνου(National and Kapodistrian University of Athens), Vassilia Chatzidakis(Harvard University)
International Journal of Cancer
September 24, 1999
Cited by 193
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k